Expion Health is set to launch Qlare™, an innovative conversational AI tool integrated into its ExpionIQ® platform, aimed at revolutionizing prescription cost management. Slated for early 2026, Qlare allows healthcare leaders to easily access and analyze prescription cost data through intuitive Q&A, enhancing decision-making speed and clarity. CEO Karin Humphrey emphasizes Qlare’s ability to simplify complex pharmacy data, empowering clients with real-time insights. This launch follows Expion’s strategic realignment in 2025, focusing on pharmacy cost management after divesting non-pharmacy ventures. The company has also expanded into the self-funded market, providing tailored pharmacy solutions for jumbo employers, leading to its recognition in the Inc. 5000 as one of America’s fastest-growing private companies. By combining advanced AI technology with industry expertise, Expion continues to drive significant cost savings for healthcare payers while maintaining quality care. For more details, visit www.expionhealth.com.
Source link
